Ingenol mebutate - LEO Pharma
At a glance
- Drug Originator National Cancer Institute (USA)
- Drug Licenced by LEO Pharma
- Drug Class Antineoplastics; Ingenols; Macrocyclic compounds; Small molecules
- Mechanism of Action Apoptosis stimulants; Immunostimulants; Protein kinase C stimulants
- USA Patent Applicants LEO LABS
- USA Patents 17
- NDAs 1
- International Patents 35
- Patent Applications 767
Table of Contents
Disclaimer